Trulieve Cannabis (TSE:TRU) Upgraded at Cormark

Cormark upgraded shares of Trulieve Cannabis (TSE:TRUFree Report) from a hold rating to a moderate buy rating in a research note published on Monday morning,Zacks.com reports.

Other equities research analysts also recently issued reports about the stock. Atb Cap Markets raised shares of Trulieve Cannabis from a “hold” rating to a “strong-buy” rating in a research report on Monday, December 9th. Craig Hallum upgraded shares of Trulieve Cannabis to a “strong-buy” rating in a report on Wednesday, February 26th.

Check Out Our Latest Research Report on TRU

Trulieve Cannabis Price Performance

Insider Activity at Trulieve Cannabis

In other news, Senior Officer Wes Getman purchased 9,500 shares of the business’s stock in a transaction dated Friday, December 13th. The stock was bought at an average price of C$7.02 per share, for a total transaction of C$66,702.35.

About Trulieve Cannabis

(Get Free Report)

TransUnion provides risk and information solutions. The company operates in three segments: U.S. Markets, International, and Consumer Interactive. The U.S. Markets segment provides consumer reports, actionable insights, and analytics to businesses. These businesses use its services to acquire new customers; assess consumer ability to pay for services; identify cross-selling opportunities; measure and manage debt portfolio risk; collect debt; verify consumer identities; and mitigate fraud risk.

Further Reading

Receive News & Ratings for Trulieve Cannabis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trulieve Cannabis and related companies with MarketBeat.com's FREE daily email newsletter.